Journal of Shanghai Jiao Tong University (Medical Science) >

2024 , Vol. 44 >Issue 8: 1044 - 1049

DOI: https://doi.org/10.3969/j.issn.1674-8115.2024.08.014

Review

Research progress in late-onset group B Streptococcus infection in infants and its prevention

  • Yibai LI ,
  • Ruiji CUI ,
  • Shan GAO ,
  • Jiajin HU ,
  • Xiaoying GUO
Expand
  • 1.The First Hospital of China Medical University, Shenyang 110122, China
    2.Department of Neonatology, Shenyang Maternity and Child Health Hospital, Liaoning Province, Shenyang 110114, China
    3.Key Laboratory of Obesity and Glucose, Lipid Associated Metabolic Diseases of Liaoning Province/Health Sciences Institute, China Medical University, Shenyang 110122, China
    4.School of Public Health, China Medical University, Shenyang 110122, China
GUO Xiaoying, E-mail: guoxy@cmu.edu.cn.

Received date: 2024-02-23

  Accepted date: 2024-07-05

  Online published: 2024-08-27

Supported by

National Natural Science Foundation of China(82103860);Undergraduate Innovative Training Program of Liaoning Province(S202310159023)

Fold

Abstract

Group B Streptococcus (GBS) is a major member of the Gram-positive Streptococcus family, which occupies a dominant position in the infection spectrum of newborns and young infants. GBS infections occurring 0?6 days after birth are called GBS early-onset disease (GBS-EOD), and those occurring 7?89 days are called GBS late-onset disease (GBS-LOD). With the use of intrapartum antibiotic prophylaxis, the incidence of neonatal GBS-EOD has declined without a notable impact on GBS-LOD, which brings great pressure and challenge to clinical diagnosis and nursing work. However, the specific mechanisms by which GBS transmission triggers illness in newborns and young infants are not fully elucidated. Some factors, such as maternal GBS colonization, maternal characteristics (age, weight and ethnicity), preterm birth, GBS infection in multiple births, and exposure to human immunodeficiency virus, have been identified as risk factors for GBS-LOD. To prevent maternal and infant GBS infection, some measures, such as vaccination of pregnant women, gut microbiota regulation and lactoferrin supplementation, are developing. In addition, strengthening maternal health care and health education, along with some other conventional infection control strategies (including enhancing hand hygiene awareness among caregivers and making good disinfection of the environment and equipment) is also effective in the prevention of GBS-LOD. This review elaborates the prevalence, transmission, risk factors and prevention of GBS-LOD in infants, aiming to improve the understanding and clinical practice ability of the medical staff.

Key words： infant; late-onset; group B Streptococcus (GBS); infection; prevention

Cite this article

Yibai LI , Ruiji CUI , Shan GAO , Jiajin HU , Xiaoying GUO . Research progress in late-onset group B Streptococcus infection in infants and its prevention[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024 , 44(8) : 1044 -1049 . DOI: 10.3969/j.issn.1674-8115.2024.08.014

References

1 GON?ALVES B P, PROCTER S R, PAUL P, et al. Group B Streptococcus infection during pregnancy and infancy: estimates of regional and global burden[J]. Lancet Glob Health, 2022, 10(6): e807-e819.
2 MADRID L, SEALE A C, KOHLI-LYNCH M, et al. Infant group B streptococcal disease incidence and serotypes worldwide: systematic review and meta-analyses[J]. Clin Infect Dis, 2017, 65(suppl_2): S160-S172.
3 JI W J, LIU H Y, MADHI S A, et al. Clinical and molecular epidemiology of invasive group B Streptococcus disease among infants, China[J]. Emerg Infect Dis, 2019, 25(11): 2021-2030.
4 DING Y J, WANG Y J, HSIA Y, et al. Systematic review and meta-analyses of incidence for group B Streptococcus disease in infants and antimicrobial resistance, China[J]. Emerg Infect Dis, 2020, 26(11): 2651-2659.
5 NANDURI S A, PETIT S, SMELSER C, et al. Epidemiology of invasive early-onset and late-onset group B streptococcal disease in the United States, 2006 to 2015: multistate laboratory and population-based surveillance[J]. JAMA Pediatr, 2019, 173(3): 224-233.
6 ZHU Y, WU J Y, ZHENG X Y, et al. Etiological serotype and genotype distributions and clinical characteristics of group B Streptococcus-inducing invasive disease among infants in South China[J]. BMC Pediatr, 2020, 20(1): 146.
7 LIU P, FENG Q L, LIANG Y H, et al. Maternal group B streptococcal rectovaginal colonization after intrapartum antibiotic prophylaxis[J]. Children (Basel), 2022, 9(12): 1848.
8 CHING N S, BUTTERY J P, LAI E, et al. Breastfeeding and risk of late-onset group B streptococcal disease[J]. Pediatrics, 2021, 148(3): e2020049561.
9 LI A Y, FANG M, HAO D J, et al. Late-onset sepsis in a premature infant mediated by breast milk: mother-to-infant transmission of group B Streptococcus detected by whole-genome sequencing[J]. Infect Drug Resist, 2022, 15: 5345-5352.
10 DELARA M, VADLAMUDI N K, SADARANGANI M. Strategies to prevent early and late-onset group B streptococcalinfection via interventions in pregnancy[J]. Pathogens, 2023, 12(2): 229.
11 MACFARQUHAR J K, JONES T F, WORON A M, et al. Outbreak of late-onset group B Streptococcus in a neonatal intensive care unit[J]. Am J Infect Control, 2010, 38(4): 283-288.
12 VAZ M J, PURRIER S A, BONAKDAR M, et al. The impact of circulating antibody on group B Streptococcus intestinal colonization and invasive disease[J]. Infect Immun, 2020, 89(1): e00348-e00320.
13 VAN KASSEL M N, JANSSEN S W C M, KOFMAN S, et al. Prevalence of group B streptococcal colonization in the healthy non-pregnant population: a systematic review and meta-analysis[J]. Clin Microbiol Infect, 2021, 27(7): 968-980.
14 Committee on Infectious Diseases, American Academy of Pediatrics, KIMBERLIN D W, BARNETT E D, et al. Red book: 2021—2024 report of the Committee on Infectious Diseases[M]. 32nd ed. Itasca, IL: American Academy of Pediatrics, 2021.
15 DOTTERS-KATZ S K, KULLER J, HEINE R P, et al. Group B Streptococcus and pregnancy: critical concepts and management nuances[J]. Obstet Gynecol Surv, 2022, 77(12): 753-762.
16 KARAMPATSAS K, DAVIES H, MYNAREK M, et al. Clinical risk factors associated with late-onset invasive group B streptococcal disease: systematic review and meta-analyses[J]. Clin Infect Dis, 2022, 75(7): 1255-1264.
17 UEDA N K, NAKAMURA K, GO H, et al. Neonatal meningitis and recurrent bacteremia with group B Streptococcus transmitted by own mother's milk: a case report and review of previous cases[J]. Int J Infect Dis, 2018, 74: 13-15.
18 TOYOFUKU M, MOROZUMI M, HIDA M, et al. Effects of intrapartum antibiotic prophylaxis on neonatal acquisition of group B Streptococci[J]. J Pediatr, 2017, 190: 169-173.e1.
19 VENKATESH K K, VLADUTIU C J, STRAUSS R A, et al. Association between maternal obesity and group B Streptococcus colonization in a national U.S. cohort[J]. J Womens Health (Larchmt), 2020, 29(12): 1507-1512.
20 CAPRARO G A, LALA S, KHALED K, et al. Association of sexually-transmitted infection and African-American race with Streptococcus agalactiae colonization in pregnancy[J]. Antimicrob Resist Infect Control, 2020, 9(1): 174.
21 KAM K Q, THOON K C, TEE W S N, et al. Serotype distribution and incidence of invasive early onset and late onset group B streptococcal disease amongst infants in Singapore[J]. BMC Infect Dis, 2021, 21(1): 1221.
22 KOLTER J, HENNEKE P. Codevelopment of microbiota and innate immunity and the risk for group B streptococcal disease[J]. Front Immunol, 2017, 8: 1497.
23 LIN F Y C, WEISMAN L E, TROENDLE J, et al. Prematurity is the major risk factor for late-onset group B Streptococcus disease[J]. J Infect Dis, 2003, 188(2): 267-271.
24 彭海波, 詹媛丽, 吴丽娟, 等. 71例小婴儿B族链球菌败血症早发型和晚发型临床分析[J]. 临床儿科杂志, 2020, 38(7): 524-529.
24 PENG H, ZHAN Y, WU L, et al. Clinical analysis of early-onset and late-onset group B Streptococcus sepsis in 71 infants[J]. Journal of Clinical Pediatrics, 2020, 38(7): 524-529.
25 FREUDENHAMMER M, KARAMPATSAS K, DOARE K L, et al. Invasive group B Streptococcus disease with recurrence and in multiples: towards a better understanding of GBS late-onset sepsis[J]. Front Immunol, 2021, 12: 617925.
26 COOLS P, VAN DE WIJGERT J H H M, JESPERS V, et al. Role of HIV exposure and infection in relation to neonatal GBS disease and rectovaginal GBS carriage: a systematic review and meta-analysis[J]. Sci Rep, 2017, 7(1): 13820.
27 MAKINDE O, OKUSANYA B O, OSANYIN G. Group B Streptococcus vaginal colonization in pregnant women living with HIV infection: prevalence and antibiotic susceptibility at HIV referral centers in Lagos, Nigeria[J]. J Matern Fetal Neonatal Med, 2022, 35(25): 9098-9104.
28 LEROUX-ROELS G, MAES C, WILLEKENS J, et al. A randomized, observer-blind Phase Ⅰb study to identify formulations and vaccine schedules of a trivalent group B Streptococcus vaccine for use in non-pregnant and pregnant women[J]. Vaccine, 2016, 34(15): 1786-1791.
29 HEATH P T. Status of vaccine research and development of vaccines for GBS[J]. Vaccine, 2016, 34(26): 2876-2879.
30 LE DOARE K, FAAL A, JAITEH M, et al. Association between functional antibody against Group B Streptococcus and maternal and infant colonization in a Gambian cohort[J]. Vaccine, 2017, 35(22): 2970-2978.
31 SONG J Y, LIM J H, LIM S, et al. Progress toward a group B streptococcal vaccine[J]. Hum Vaccin Immunother, 2018, 14(11): 2669-2681.
32 HILLIER S L, FERRIERI P, EDWARDS M S, et al. A phase 2, randomized, control trial of group B Streptococcus (GBS) type Ⅲ capsular polysaccharide-tetanus toxoid (GBS Ⅲ-TT) vaccine to prevent vaginal colonization with GBS Ⅲ[J]. Clin Infect Dis, 2019, 68(12): 2079-2086.
33 ABSALON J, SEGALL N, BLOCK S L, et al. Safety and immunogenicity of a novel hexavalent group B Streptococcus conjugate vaccine in healthy, non-pregnant adults: a phase 1/2, randomised, placebo-controlled, observer-blinded, dose-escalation trial[J]. Lancet Infect Dis, 2021, 21(2): 263-274.
34 BIANCHI-JASSIR F, PAUL P, TO K N, et al. Systematic review of group B streptococcal capsular types, sequence types and surface proteins as potential vaccine candidates[J]. Vaccine, 2020, 38(43): 6682-6694.
35 MAELAND J A, AFSET J E, LYNG R V, et al. Survey of immunological features of the alpha-like proteins of Streptococcus agalactiae[J]. Clin Vaccine Immunol, 2015, 22(2): 153-159.
36 RAO S C, ATHALYE-JAPE G K, DESHPANDE G C, et al. Probiotic supplementation and late-onset sepsis in preterm infants: a meta-analysis[J]. Pediatrics, 2016, 137(3): e20153684.
37 HAYES K, O'HALLORAN F, COTTER L. A review of antibiotic resistance in group B Streptococcus: the story so far[J]. Crit Rev Microbiol, 2020, 46(3): 253-269.
38 TADROS J S, LLERENA A, SARKAR A, et al. Postnatal growth and gut microbiota development influenced early childhood growth in preterm infants[J]. Front Pediatr, 2022, 10: 850629.
39 RAZAK A, HUSSAIN A. Lactoferrin supplementation to prevent late-onset sepsis in preterm infants: a meta-analysis[J]. Am J Perinatol, 2021, 38(3): 283-290.
Options
Outlines

/

〈 〉